The	O
SCA3	O
intestinal	O
mucosal	O
crypts	O
were	O
immunostained	O
for	O
the	O
presence	O
of	O
polyglutamine	O
aggregates	O
with	O
polyclonal	O
anti–ataxin-3	PROT
or	O
monoclonal	O
anti-polyglutamine	O
IC2	O
antibodies.We	O
sequence	O
the	O
top	O
candidate	O
regions	O
,	O
5.8	O
Mb	O
in	O
total	O
,	O
and	O
find	O
that	O
four	O
genes	O
,	O
all	O
with	O
synaptic	O
function	O
,	O
are	O
enriched	O
for	O
case-specific	O
variants	O
:	O
neuronal-cadherin	O
CDH2	O
,	O
catenin	O
alpha2	O
CTNNA2	O
,	O
ataxin-1	PROT
ATXN1	O
,	O
and	O
plasma	O
glutamate	O
carboxypeptidase	O
PGCP	O
.	O
Our	O
experimental	O
study	O
covers	O
a	O
variety	O
of	O
data	O
distributions	O
that	O
occur	O
in	O
practice	O
.	O
A	O
293T	O
cells	O
were	O
transfected	O
with	O
the	O
indicated	O
Flag-ataxin-3	PROT
full-length	O
or	O
its	O
mutants.Thus	O
,	O
it	O
is	O
plausible	O
that	O
a	O
large	O
expansion	O
of	O
the	O
ATTCT	O
repeat	O
may	O
interfere	O
with	O
the	O
transcription	O
,	O
like	O
the	O
GAA	O
repeat	O
expansion	O
does	O
in	O
FRDA	O
,	O
leading	O
to	O
a	O
loss	O
of	O
function	O
of	O
ataxin	PROT
10	O
.	O
Fibroblasts	O
were	O
transfected	O
using	O
the	O
human	O
dermal	O
fibroblast	O
nucleofector	O
kit	O
for	O
electroporation	O
Amaxa	O
Corporation.This	O
interaction	O
was	O
also	O
found	O
to	O
have	O
pathogenic	O
implications	O
since	O
SCA1	O
triplet	O
repeats	O
are	O
significantly	O
increased	O
in	O
ALS	O
patients	O
as	O
compared	O
to	O
controls	O
46	O
.	O
Further	O
,	O
recent	O
genetic	O
studies	O
have	O
shown	O
that	O
mutations	O
in	O
Ataxin-2	PROT
and	O
VCP	O
are	O
prevalent	O
in	O
ALS	O
patients	O
,	O
with	O
intermediate	O
polyglutamine	O
expansions	O
significantly	O
associated	O
with	O
ALS	O
46	O
and	O
a	O
study	O
finding	O
VCP	O
mutations	O
in	O
1–2	O
%	O
of	O
FALS	O
patients	O
72.Further	O
evidence	O
for	O
a	O
determined	O
assembly	O
order	O
of	O
SGs	O
comes	O
from	O
the	O
observation	O
that	O
in	O
budding	O
yeast	O
cells	O
upon	O
mild	O
heat	O
shock	O
,	O
translation	O
factors	O
form	O
foci	O
at	O
sites	O
where	O
SGs	O
will	O
later	O
form	O
when	O
the	O
temperature	O
is	O
raised	O
further	O
26	O
.	O
Although	O
these	O
data	O
suggest	O
that	O
ataxin	PROT
10	O
plays	O
a	O
role	O
in	O
neuronal	O
survival	O
and	O
differentiation	O
,	O
the	O
exact	O
function	O
of	O
ataxin	PROT
10	O
remains	O
unknown.By	O
gold-substituted	O
silver	O
peroxidase	O
,	O
DAB	O
was	O
converted	O
into	O
gold	O
label	O
suitable	O
for	O
electron	O
microscopy	O
.	O
Similar	O
data	O
were	O
obtained	O
with	O
the	O
anti–ataxin-3	PROT
antibody	O
unpublished	O
data.The	O
SCA3	O
intestinal	O
mucosal	O
crypts	O
were	O
immunostained	O
for	O
the	O
presence	O
of	O
polyglutamine	O
aggregates	O
with	O
polyclonal	O
anti–ataxin-3	PROT
or	O
monoclonal	O
anti-polyglutamine	O
IC2	O
antibodies	O
.	O
Thus	O
,	O
SGs	O
can	O
form	O
after	O
azide	O
treatment	O
independently	O
of	O
PB	O
formation	O
ability	O
or	O
of	O
the	O
mRNA-binding	O
proteins	O
Pbp1	O
Ataxin-2	PROT
homolog	O
and	O
Pub1	O
TIA-1	O
homolog	O
,	O
but	O
not	O
after	O
glucose	O
deprivation	O
25.Mutations	O
in	O
the	O
human	O
A2BP1	O
gene	O
have	O
since	O
been	O
associated	O
with	O
several	O
other	O
neurological	O
syndromes	O
,	O
including	O
mental	O
retardation	O
,	O
epilepsy	O
,	O
and	O
autism	O
spectrum	O
disorders	O
54-57	O
.	O
The	O
LUVHIV-tRed	O
lipid	O
composition	O
was	O
:	O
POPC	O
25	O
mol	O
%	O
:	O
1,2-dipalmitoyl-sn-glycero-3-phosphocholine	O
(	O
DPPC	O
)	O
16	O
mol	O
%	O
:	O
brain	O
sphingomyelin	O
(	O
SM	O
)	O
14	O
mol	O
%	O
:	O
cholesterol	O
(	O
Chol	O
)	O
45	O
mol	O
%	O
,	O
and	O
when	O
Cer	O
,	O
PS	O
,	O
or	O
gangliosides	O
were	O
present	O
(	O
4	O
mol	O
%	O
)	O
the	O
SM	O
amount	O
was	O
reduced	O
to	O
10	O
mol	O
%	O
.	O
Human	O
intestine	O
tissue	O
that	O
was	O
obtained	O
from	O
deceased	O
SCA3	O
patients	O
24	O
h	O
after	O
death	O
was	O
fixed	O
in	O
4	O
%	O
para-formaldehyde	O
and	O
cryosectioned	O
in	O
50-μm	O
sections.Cell	O
lysates	O
were	O
immunoprecipitated	O
by	O
M2	O
beads	O
,	O
and	O
the	O
bound	O
proteins	O
were	O
analyzed	O
by	O
immunoblotting	O
with	O
anti-p53	O
polyclonal	O
antibody	O
.	O
Our	O
results	O
confirm	O
that	O
hyper-editing	O
,	O
concentrated	O
in	O
repetitive	O
elements	O
,	O
has	O
the	O
potential	O
to	O
destabilize	O
and	O
eliminate	O
the	O
dangerous	O
dsRNA	O
structures	O
.	O
To	O
identify	O
cis-elements	O
responsible	O
for	O
CAG	O
expansion	O
at	O
the	O
SCA7	O
locus	O
,	O
we	O
previously	O
introduced	O
SCA7	O
CAG-92	O
repeat	O
expansions	O
into	O
mice	O
,	O
either	O
on	O
13.5	O
kb	O
ataxin-7	PROT
genomic	O
fragments	O
or	O
on	O
ataxin-7	PROT
cDNAs.As	O
deletion	O
of	O
the	O
3′	O
region	O
in	O
the	O
α-SCA7-92R	O
transgenic	O
mice	O
significantly	O
stabilized	O
the	O
CAG-92	O
tract	O
13	O
,	O
we	O
hypothesized	O
that	O
cis-elements	O
within	O
this	O
3′	O
region	O
modify	O
repeat	O
instability	O
at	O
the	O
SCA7	O
locus	O
.	O
They	O
found	O
that	O
genes	O
involved	O
in	O
oxidative	O
phosphorylation	O
were	O
coordinately	O
down	O
regulated	O
in	O
human	O
diabetes	O
.	O
Human	O
A2BP1	O
was	O
first	O
identified	O
through	O
its	O
interaction	O
with	O
Ataxin-2	PROT
,	O
the	O
protein	O
mutated	O
in	O
spinocerebellar	O
ataxia	O
type	O
II	O
53.These	O
inclusions	O
were	O
not	O
detected	O
in	O
the	O
intestinal	O
crypts	O
of	O
healthy	O
controls	O
,	O
and	O
moreover	O
,	O
the	O
expression	O
levels	O
of	O
the	O
ataxin-3	PROT
protein	O
seemed	O
equal	O
in	O
all	O
cell	O
types	O
,	O
including	O
the	O
putative	O
stem	O
cells	O
see	O
below	O
.	O
A2BP1	O
belongs	O
to	O
a	O
family	O
of	O
RNA	O
binding	O
proteins	O
that	O
is	O
composed	O
of	O
two	O
other	O
homolog	O
splicing	O
factors	O
,	O
RBFOX2	O
RBM9	O
or	O
FOX-2	O
and	O
RBFOX3	O
HRNBP3	O
,	O
NEUN	O
,	O
or	O
FOX-3.Expansion	O
of	O
an	O
unstable	O
CAG	O
repeat	O
in	O
the	O
first	O
coding	O
exon	O
of	O
the	O
SCA7	O
gene	O
,	O
resulting	O
in	O
an	O
expanded	O
polyglutamine	O
domain	O
in	O
the	O
N-terminal	O
of	O
the	O
ataxin-7	PROT
ATXN7	O
protein	O
causes	O
the	O
disease	O
3	O
.	O
This	O
indicates	O
that	O
in	O
both	O
patients	O
aged	O
87	O
y	O
and	O
64	O
y	O
at	O
time	O
of	O
death	O
,	O
intestinal	O
stem	O
cells	O
that	O
were	O
supposed	O
to	O
have	O
accumulated	O
mutant	O
ataxin-3	PROT
over	O
the	O
course	O
of	O
patients	O
'	O
entire	O
lives	O
were	O
devoid	O
of	O
large	O
aggregates	O
,	O
whereas	O
the	O
short-lived	O
committed	O
and	O
differentiated	O
cells	O
did	O
contain	O
such	O
polyglutamine	O
aggregates.D	O
GST-pull	O
down	O
assay	O
was	O
performed	O
with	O
the	O
GST-Ub	O
chains	O
and	O
the	O
whole	O
cell	O
extract	O
of	O
293T	O
transiently	O
transfected	O
with	O
indicated	O
Flag-tagged	O
ataxin-3	PROT
and	O
its	O
mutants	O
.	O
GST	O
proteins	O
were	O
stained	O
by	O
Ponceau	O
S	O
,	O
and	O
the	O
pulled	O
down	O
proteins	O
were	O
analyzed	O
by	O
immunoblotting	O
with	O
anti-p53	O
polyclonal	O
antibody.G	O
HCT116	O
p53++	O
and	O
HCT116	O
p53	O
--	O
ataxin-3-stably	PROT
knockdown	O
cells	O
were	O
fixed	O
,	O
stained	O
with	O
PI	O
,	O
and	O
analyzed	O
by	O
flow	O
cytometry	O
.	O
However	O
,	O
we	O
did	O
not	O
observe	O
any	O
significant	O
rescue	O
of	O
the	O
Mdm2	O
MO-induced	O
cell	O
death	O
with	O
the	O
Mdm2	O
RNA	O
construct	O
(	O
unpublished	O
data	O
)	O
.	O
Plasmids	O
expressing	O
either	O
12	O
or	O
500	O
ATTCT	O
repeats	O
were	O
transfected	O
at	O
3	O
µg	O
according	O
to	O
kit	O
instructions	O
,	O
and	O
siRNA	O
both	O
hnRNP	O
K	O
and	O
ataxin	PROT
10	O
was	O
transfected	O
according	O
to	O
kit	O
instructions.Intestinal	O
tissue	O
contains	O
stem	O
cells	O
that	O
give	O
rise	O
to	O
short-lived	O
committed	O
progenitors	O
and	O
differentiated	O
cells	O
.	O
In	O
the	O
absence	O
of	O
the	O
Elongator	O
complex	O
alone	O
,	O
some	O
hypo-acetylation	O
of	O
histones	O
likely	O
occurs	O
,	O
thereby	O
compromising	O
chromatin	O
assembly	O
,	O
but	O
this	O
is	O
not	O
sufficient	O
to	O
kill	O
the	O
cells	O
.	O
While	O
ATXN10	O
is	O
expressed	O
in	O
a	O
wide	O
variety	O
of	O
tissues	O
,	O
expression	O
is	O
especially	O
strong	O
in	O
brain	O
,	O
heart	O
and	O
muscle.SCA3	O
is	O
caused	O
by	O
an	O
unstable	O
cytosine-adenine-guanine	O
CAG	O
trinucleotide	O
expansion	O
mutation	O
in	O
the	O
ATXN3	O
gene	O
leading	O
to	O
an	O
expanded	O
polyQ	O
tract	O
within	O
the	O
ataxin-3	PROT
ATX-3	O
protein	O
4	O
.	O
This	O
interaction	O
was	O
also	O
conserved	O
in	O
nuclear	O
extracts	O
from	O
LNCaP	O
(	O
human	O
prostate	O
adenocarcinoma	O
)	O
cells	O
(	O
Figure	O
2C	O
)	O
.	O
A-B	O
Imaging	O
A	O
and	O
western	O
blot	O
analysis	O
B	O
of	O
293T	O
cells	O
infected	O
with	O
lentiviral	O
vectors	O
encoding	O
ATX-3-WT	O
or	O
mutant	O
ATX-3	O
ATX-3-80Q	O
or	O
ATX-3-C14A	O
containing	O
a	O
EGFP	O
tag	O
at	O
5	O
days	O
post-infection.Because	O
double	O
staining	O
with	O
the	O
Musashi-1	O
antibody	O
and	O
the	O
anti-polyglutamine	O
or	O
anti–ataxin-3	PROT
antibody	O
was	O
not	O
possible	O
,	O
we	O
identified	O
putative	O
stem	O
cells	O
in	O
the	O
crypts	O
on	O
the	O
basis	O
of	O
their	O
localisation	O
next	O
to	O
the	O
Paneth	O
cells	O
.	O
Spinocerebellar	O
ataxia	O
type	O
3	O
SCA3	O
,	O
also	O
known	O
as	O
Machado–Joseph	O
disease	O
MJD	O
,	O
is	O
an	O
autosomal-dominantly	O
inherited	O
ataxia	O
and	O
one	O
of	O
at	O
least	O
nine	O
polyglutamine	O
polyQ	O
neurodegenerative	O
disorders	O
described	O
so	O
far	O
1–3.These	O
combined	O
results	O
suggest	O
that	O
TARDBP	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
pathogenic	O
pathways	O
leading	O
to	O
motor	O
neuron	O
degeneration	O
culminating	O
in	O
ALS	O
.	O
Another	O
recent	O
example	O
is	O
the	O
identification	O
of	O
interactions	O
between	O
TDP-43	O
and	O
ataxin-2	PROT
in	O
vivo	O
,	O
with	O
ataxin-2	PROT
containing	O
polyglutamine	O
expansions	O
being	O
a	O
potent	O
modifier	O
of	O
TDP-43	O
toxicity	O
.	O
Primers	O
used	O
were	O
:	O
rat	O
glyceraldehyde	O
3-phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
(	O
PPR06557A	O
Superarray	O
)	O
,	O
rat	O
CXCR4	O
(	O
5	O
'	O
AGGAACTGAACGCTCCAGAA	O
3	O
'	O
and	O
5	O
'	O
AACCACACAGCACAACCAAA	O
3	O
'	O
)	O
,	O
human	O
CXCR4	O
(	O
5	O
'	O
CTCCAAGCTGTCACACTCCA	O
3	O
'	O
and	O
5	O
'	O
TCGATGCTGATCCCAATGTA	O
3	O
'	O
)	O
,	O
human	O
and	O
rat	O
CXCR7	O
(	O
5	O
'	O
GCACTACATCCCGTTCACCT	O
3	O
'	O
and	O
5'AAGGCCTTCATCAGCTCGTA	O
3	O
'	O
)	O
.	O
*	O
denotes	O
P	O
<	O
0.05	O
,	O
and	O
**	O
denotes	O
P	O
<	O
0.01.Interestingly	O
,	O
mutant	O
ataxin-3	PROT
,	O
which	O
is	O
the	O
protein	O
product	O
of	O
the	O
gene	O
mutated	O
in	O
spinocerebellar	O
ataxia	O
type	O
3	O
SCA3	O
,	O
was	O
shown	O
to	O
bind	O
to	O
ITPR1	O
and	O
thereby	O
cause	O
a	O
destabilization	O
of	O
neuronal	O
calcium	O
signaling	O
18	O
.	O
DAB	O
label	O
was	O
generated	O
by	O
GARRAM	O
biotin	O
1:400	O
and	O
VectaStain	O
ABC	O
1:400.This	O
indicates	O
that	O
in	O
both	O
patients	O
aged	O
87	O
y	O
and	O
64	O
y	O
at	O
time	O
of	O
death	O
,	O
intestinal	O
stem	O
cells	O
that	O
were	O
supposed	O
to	O
have	O
accumulated	O
mutant	O
ataxin-3	PROT
over	O
the	O
course	O
of	O
patients	O
'	O
entire	O
lives	O
were	O
devoid	O
of	O
large	O
aggregates	O
,	O
whereas	O
the	O
short-lived	O
committed	O
and	O
differentiated	O
cells	O
did	O
contain	O
such	O
polyglutamine	O
aggregates	O
.	O
HCT116	O
p53++	O
and	O
HCT116	O
p53	O
--	O
cells	O
transiently	O
transfected	O
with	O
Flag-ataxin-3-80Q	PROT
or	O
Flag-ataxin-3	PROT
were	O
left	O
untreated	O
upper	O
or	O
treated	O
with	O
1μM	O
of	O
CPT	O
lower	O
for	O
24h.If	O
the	O
principle	O
of	O
asymmetric	O
distribution	O
of	O
damage	O
indeed	O
holds	O
true	O
for	O
proliferating	O
tissues	O
,	O
it	O
may	O
enable	O
mitotically	O
competent	O
cells	O
to	O
avoid	O
the	O
risk	O
of	O
accumulating	O
toxic	O
protein	O
aggregates	O
during	O
ageing	O
,	O
or	O
in	O
the	O
case	O
of	O
protein	O
misfolding	O
diseases	O
,	O
thus	O
preserving	O
the	O
cells	O
'	O
capacity	O
to	O
produce	O
progeny	O
.	O
The	O
PCDM	O
is	O
a	O
rather	O
complex	O
model	O
that	O
contains	O
many	O
functional	O
groups	O
,	O
and	O
dozens	O
of	O
entities	O
.	O
5	O
were	O
extracted	O
,	O
and	O
exon	O
10	O
of	O
the	O
PRLR	O
was	O
sequenced	O
.	O
Further	O
,	O
recent	O
genetic	O
studies	O
have	O
shown	O
that	O
mutations	O
in	O
Ataxin-2	PROT
and	O
VCP	O
are	O
prevalent	O
in	O
ALS	O
patients	O
,	O
with	O
intermediate	O
polyglutamine	O
expansions	O
significantly	O
associated	O
with	O
ALS	O
46	O
and	O
a	O
study	O
finding	O
VCP	O
mutations	O
in	O
1–2	O
%	O
of	O
FALS	O
patients	O
72	O
.	O
Similarly	O
,	O
NEK4	O
interacts	O
with	O
the	O
known	O
ciliopathy	O
protein	O
RPGRIP1L	O
(	O
mutations	O
in	O
RPGRIP1L	O
are	O
causative	O
for	O
Joubert	O
and	O
Meckel-Gruber	O
syndromes	O
)	O
,	O
is	O
localized	O
to	O
the	O
basal	O
body	O
in	O
ciliated	O
cells	O
,	O
and	O
its	O
deficiency	O
impairs	O
cilium	O
assembly	O
.	O
Total	O
RNAs	O
from	O
30	O
microdissected	O
pituitaries	O
at	O
E12.5	O
and	O
E17.5	O
were	O
isolated	O
using	O
miRNAeasy	O
kit	O
(	O
Qiagen	O
)	O
to	O
interrogate	O
a	O
human/mouse/rat	O
miRNA	O
array	O
(	O
LC	O
Sciences	O
)	O
comprising	O
a	O
total	O
of	O
1256	O
unique	O
mature	O
miRNAs	O
(	O
837	O
human	O
,	O
599	O
mouse	O
,	O
and	O
350	O
rat	O
,	O
based	O
on	O
Sanger	O
miRBase	O
11.0	O
;	O
Sanger	O
Institute	O
,	O
Hinxton	O
,	O
UK	O
)	O
.	O
(	O
E	O
)	O
Same	O
as	O
A	O
for	O
SA	O
in	O
control	O
and	O
Brca2-depleted	O
(	O
iBrca2	O
)	O
cells	O
.	O
In	O
agreement	O
with	O
earlier	O
data	O
21–23	O
,	O
the	O
Musashi-1	O
antibody	O
indeed	O
decorated	O
cells	O
adjacent	O
to	O
or	O
in	O
between	O
the	O
Paneth	O
cells	O
Figure	O
4B	O
and	O
4C	O
,	O
further	O
supporting	O
the	O
idea	O
that	O
these	O
are	O
the	O
stem	O
cells	O
within	O
the	O
intestinal	O
epithelium.Similar	O
results	O
were	O
found	O
in	O
skin	O
tissues	O
unpublished	O
data	O
.	O
To	O
test	O
the	O
functionality	O
of	O
this	O
region	O
of	O
the	O
lncRNA	O
,	O
we	O
first	O
generated	O
a	O
truncated	O
form	O
of	O
LINC-PINT	O
that	O
lacks	O
the	O
conserved	O
nucleotides	O
and	O
only	O
contains	O
the	O
516	O
nt	O
5′	O
of	O
the	O
lncRNA	O
(	O
lowly	O
conserved	O
region	O
,	O
Fig	O
.	O
Our	O
results	O
clearly	O
demonstrate	O
that	O
the	O
conditional	O
genetic	O
deletion	O
of	O
a	O
single	O
core	O
desmosomal	O
component	O
,	O
Dsp	O
,	O
promotes	O
increased	O
local	O
tumor	O
invasion	O
in	O
RT2	O
mice	O
,	O
producing	O
a	O
phenocopy	O
of	O
such	O
inferred	O
transcriptional	O
regulation	O
in	O
the	O
normal	O
circumstances	O
of	O
tumor	O
progression.Human	O
A2BP1	O
was	O
first	O
identified	O
through	O
its	O
interaction	O
with	O
Ataxin-2	PROT
,	O
the	O
protein	O
mutated	O
in	O
spinocerebellar	O
ataxia	O
type	O
II	O
53	O
.	O
Because	O
double	O
staining	O
with	O
the	O
Musashi-1	O
antibody	O
and	O
the	O
anti-polyglutamine	O
or	O
anti–ataxin-3	PROT
antibody	O
was	O
not	O
possible	O
,	O
we	O
identified	O
putative	O
stem	O
cells	O
in	O
the	O
crypts	O
on	O
the	O
basis	O
of	O
their	O
localisation	O
next	O
to	O
the	O
Paneth	O
cells.This	O
inappropriate	O
regulation	O
of	O
Dsc2	O
might	O
contribute	O
to	O
desmosome	O
dysregulation	O
.	O
As	O
deletion	O
of	O
the	O
3′	O
region	O
in	O
the	O
α-SCA7-92R	O
transgenic	O
mice	O
significantly	O
stabilized	O
the	O
CAG-92	O
tract	O
,	O
we	O
hypothesized	O
that	O
cis-elements	O
within	O
this	O
3′	O
region	O
modify	O
repeat	O
instability	O
at	O
the	O
SCA7	O
locus	O
.	O
However	O
,	O
there	O
was	O
also	O
a	O
significant	O
negative	O
effect	O
of	O
ND2	O
proteins	O
on	O
the	O
occurrence	O
of	O
the	O
ATP6	O
A	O
protein	O
,	O
independent	O
of	O
the	O
other	O
fixed	O
factors/variables	O
.	O
a	O
To	O
initiate	O
silencing	O
,	O
the	O
Krüppel-associated	O
box	O
(	O
KRAB	O
)	O
zinc	O
finger	O
protein	O
(	O
Zfp	O
)	O
Zfp809	O
interacts	O
with	O
the	O
proline	O
primer	O
binding	O
site	O
(	O
PBS	O
Pro	O
)	O
of	O
some	O
ERV	O
families	O
(	O
e.g.	O
,	O
Moloney	O
murine	O
leukemia	O
virus	O
)	O
whereas	O
other	O
KRAB-Zfps	O
bind	O
to	O
a	O
short	O
heterochromatin-inducing	O
(	O
SHIN	O
)	O
sequence	O
found	O
in	O
intracisternal	O
A-type	O
particle	O
retrotransposons	O
and	O
other	O
ERV	O
families	O
.	O
Annexin	O
V	O
binds	O
to	O
the	O
outer	O
leaflet	O
lipid	O
phosphatidylserine	O
(	O
PS	O
)	O
that	O
is	O
exposed	O
during	O
MP	O
biogenesis	O
.	O
Class	O
I	O
is	O
represented	O
by	O
the	O
retrotransposons	O
(	O
long	O
interspersed	O
nucleotide	O
elements	O
,	O
short	O
interspersed	O
nucleotide	O
elements	O
,	O
long	O
terminal	O
repeats	O
,	O
and	O
endogenous	O
retrovirus	O
)	O
.	O
Mutation	O
of	O
Ip3r1	O
underlies	O
ataxia	O
in	O
mice	O
and	O
mutations	O
in	O
ITPR1	O
have	O
been	O
identified	O
in	O
spinocerebellar	O
ataxia	O
15	O
in	O
humans	O
.	O
Interestingly	O
,	O
APOBEC3B	O
expression	O
correlated	O
with	O
sensitivity	O
to	O
the	O
Chk1	O
inhibitor	O
CCT244747	O
(	O
Additional	O
file	O
10	O
:	O
Figure	O
S10e	O
)	O
.	O
Another	O
recent	O
example	O
is	O
the	O
identification	O
of	O
interactions	O
between	O
TDP-43	O
and	O
ataxin-2	PROT
in	O
vivo	O
,	O
with	O
ataxin-2	PROT
containing	O
polyglutamine	O
expansions	O
being	O
a	O
potent	O
modifier	O
of	O
TDP-43	O
toxicity	O
46.However	O
,	O
we	O
recently	O
demonstrated	O
that	O
neither	O
a	O
gain	O
nor	O
a	O
loss	O
of	O
the	O
function	O
of	O
ATXN10	O
is	O
the	O
primary	O
pathogenic	O
mechanism	O
of	O
SCA10	O
17	O
.	O
Patients	O
with	O
late	O
stage	O
diseases	O
(	O
stages	O
III	O
and	O
IV	O
)	O
accounted	O
for	O
only	O
10.3	O
%	O
.	O
This	O
arises	O
because	O
Sxl	O
,	O
a	O
female-specific	O
RNA-binding	O
protein	O
,	O
negatively	O
regulates	O
Notch	O
signaling	O
during	O
larval	O
and	O
follicular	O
epithelium	O
development	O
,	O
by	O
binding	O
to	O
N	O
mRNA	O
to	O
control	O
Notch	O
translation	O
.	O
Most	O
of	O
these	O
interactors	O
are	O
mutated	O
in	O
other	O
neurodegenerative	O
disorders	O
,	O
such	O
as	O
dementia	O
and	O
expanded	O
polyglutamine	O
repeat	O
disorders	O
,	O
whereas	O
some	O
may	O
participate	O
in	O
generalized	O
processes	O
such	O
as	O
autophagy.Immunohistochemistry	O
of	O
ataxin-3	PROT
was	O
performed	O
with	O
a	O
polyclonal	O
antibody	O
against	O
the	O
full-length	O
protein	O
a	O
generous	O
gift	O
from	O
H.	O
Paulson	O
,	O
Iowa	O
City	O
,	O
United	O
States	O
diluted	O
1:5000	O
and	O
with	O
a	O
polyglutamine-expansion	O
specific	O
mouse	O
1C2	O
Chemicon	O
;	O
MAB	O
1574	O
diluted	O
1:3000	O
.	O
Using	O
both	O
light	O
and	O
electron	O
microscopy	O
,	O
we	O
found	O
that	O
in	O
both	O
patients	O
,	O
committed	O
differentiated	O
epithelial	O
cells	O
Figure	O
4D	O
and	O
4E	O
,	O
dividing	O
transit	O
cells	O
Figure	O
4F	O
and	O
4I	O
,	O
as	O
well	O
as	O
the	O
adjacent	O
nondividing	O
differentiated	O
Paneth	O
cells	O
Figure	O
4J	O
in	O
the	O
crypts	O
contained	O
large	O
polyglutamine	O
cytoplasmic	O
inclusions	O
as	O
recognised	O
by	O
the	O
anti-polyglutamine	O
antibody.This	O
pattern	O
of	O
distribution	O
may	O
also	O
be	O
conserved	O
in	O
humans	O
,	O
where	O
we	O
found	O
that	O
aggregated	O
mutant	O
ataxin-3	PROT
is	O
absent	O
in	O
the	O
long-lived	O
stem	O
cells	O
of	O
the	O
intestinal	O
crypts	O
but	O
present	O
in	O
a	O
large	O
fraction	O
of	O
the	O
shorter-lived	O
,	O
more	O
differentiated	O
daughter	O
cells	O
.	O
G	O
HCT116	O
p53++	O
and	O
HCT116	O
p53	O
--	O
ataxin-3-stably	PROT
knockdown	O
cells	O
were	O
fixed	O
,	O
stained	O
with	O
PI	O
,	O
and	O
analyzed	O
by	O
flow	O
cytometry.To	O
identify	O
cis-elements	O
responsible	O
for	O
CAG	O
expansion	O
at	O
the	O
SCA7	O
locus	O
,	O
we	O
previously	O
introduced	O
SCA7	O
CAG-92	O
repeat	O
expansions	O
into	O
mice	O
,	O
either	O
on	O
13.5	O
kb	O
ataxin-7	PROT
genomic	O
fragments	O
or	O
on	O
ataxin-7	PROT
cDNAs	O
.	O
We	O
identified	O
several	O
components	O
of	O
desmosomes	O
–	O
Dsp	O
,	O
Dsg2	O
,	O
desmocollin	PROT
2	O
Dsc2	O
;	O
MGI	O
:	O
103221	O
,	O
and	O
plakophilin	O
2	O
Pkp2	O
;	O
MGI	O
:	O
1914701	O
–	O
whose	O
expression	O
was	O
significantly	O
downregulated	O
in	O
the	O
highly	O
invasive	O
tumor	O
lesions	O
that	O
develop	O
in	O
the	O
RT2	O
mouse	O
model	O
of	O
PNET.Plasmids	O
expressing	O
either	O
12	O
or	O
500	O
ATTCT	O
repeats	O
were	O
transfected	O
at	O
3	O
µg	O
according	O
to	O
kit	O
instructions	O
,	O
and	O
siRNA	O
both	O
hnRNP	O
K	O
and	O
ataxin	PROT
10	O
was	O
transfected	O
according	O
to	O
kit	O
instructions	O
.	O
This	O
pattern	O
of	O
distribution	O
may	O
also	O
be	O
conserved	O
in	O
humans	O
,	O
where	O
we	O
found	O
that	O
aggregated	O
mutant	O
ataxin-3	PROT
is	O
absent	O
in	O
the	O
long-lived	O
stem	O
cells	O
of	O
the	O
intestinal	O
crypts	O
but	O
present	O
in	O
a	O
large	O
fraction	O
of	O
the	O
shorter-lived	O
,	O
more	O
differentiated	O
daughter	O
cells.Although	O
these	O
data	O
suggest	O
that	O
ataxin	PROT
10	O
plays	O
a	O
role	O
in	O
neuronal	O
survival	O
and	O
differentiation	O
,	O
the	O
exact	O
function	O
of	O
ataxin	PROT
10	O
remains	O
unknown	O
.	O
So	O
,	O
also	O
in	O
Drosophila	O
the	O
polarity	O
is	O
arranged	O
to	O
avoid	O
accumulation	O
of	O
damaged	O
proteins	O
in	O
the	O
longest-lived	O
daughter	O
cell.HCT116	O
p53++	O
and	O
HCT116	O
p53	O
--	O
cells	O
transiently	O
transfected	O
with	O
Flag-ataxin-3-80Q	PROT
or	O
Flag-ataxin-3	PROT
were	O
left	O
untreated	O
upper	O
or	O
treated	O
with	O
1μM	O
of	O
CPT	O
lower	O
for	O
24h	O
.	O
Interestingly	O
,	O
mutant	O
ataxin-3	PROT
,	O
which	O
is	O
the	O
protein	O
product	O
of	O
the	O
gene	O
mutated	O
in	O
spinocerebellar	O
ataxia	O
type	O
3	O
SCA3	O
,	O
was	O
shown	O
to	O
bind	O
to	O
ITPR1	O
and	O
thereby	O
cause	O
a	O
destabilization	O
of	O
neuronal	O
calcium	O
signaling	O
18.Using	O
both	O
light	O
and	O
electron	O
microscopy	O
,	O
we	O
found	O
that	O
in	O
both	O
patients	O
,	O
committed	O
differentiated	O
epithelial	O
cells	O
Figure	O
4D	O
and	O
4E	O
,	O
dividing	O
transit	O
cells	O
Figure	O
4F	O
and	O
4I	O
,	O
as	O
well	O
as	O
the	O
adjacent	O
nondividing	O
differentiated	O
Paneth	O
cells	O
Figure	O
4J	O
in	O
the	O
crypts	O
contained	O
large	O
polyglutamine	O
cytoplasmic	O
inclusions	O
as	O
recognised	O
by	O
the	O
anti-polyglutamine	O
antibody	O
.	O
Although	O
the	O
ataxin-3	PROT
protein	O
is	O
known	O
to	O
be	O
ubiquitously	O
expressed	O
41	O
and	O
was	O
also	O
detected	O
in	O
stem	O
cells	O
in	O
the	O
intestine	O
Figure	O
4	O
,	O
we	O
can	O
not	O
exclude	O
the	O
possibility	O
that	O
the	O
lack	O
of	O
large	O
aggregates	O
in	O
the	O
stem	O
cells	O
is	O
possibly	O
also	O
due	O
to	O
a	O
lower	O
expression	O
of	O
the	O
protein.Thus	O
,	O
SGs	O
can	O
form	O
after	O
azide	O
treatment	O
independently	O
of	O
PB	O
formation	O
ability	O
or	O
of	O
the	O
mRNA-binding	O
proteins	O
Pbp1	O
Ataxin-2	PROT
homolog	O
and	O
Pub1	O
TIA-1	O
homolog	O
,	O
but	O
not	O
after	O
glucose	O
deprivation	O
25	O
.	O
AMS	O
resembles	O
a	O
classic	O
information	O
retrieval	O
scenario	O
,	O
whereby	O
the	O
systems	O
being	O
evaluated	O
are	O
expected	O
to	O
return	O
a	O
ranked	O
list	O
of	O
audio	O
items	O
that	O
are	O
considered	O
similar	O
to	O
a	O
given	O
query	O
DATA	O
We	O
compiled	O
26024	O
human	O
judgments	O
of	O
audio	O
similarity	O
across	O
four	O
years	O
of	O
MIREX	O
's	O
AMS	O
judgments	O
.	O
D	O
GST-pull	O
down	O
assay	O
was	O
performed	O
with	O
the	O
GST-Ub	O
chains	O
and	O
the	O
whole	O
cell	O
extract	O
of	O
293T	O
transiently	O
transfected	O
with	O
indicated	O
Flag-tagged	O
ataxin-3	PROT
and	O
its	O
mutants.Most	O
of	O
these	O
interactors	O
are	O
mutated	O
in	O
other	O
neurodegenerative	O
disorders	O
,	O
such	O
as	O
dementia	O
and	O
expanded	O
polyglutamine	O
repeat	O
disorders	O
,	O
whereas	O
some	O
may	O
participate	O
in	O
generalized	O
processes	O
such	O
as	O
autophagy	O
.	O
As	O
expected	O
,	O
the	O
expression	O
level	O
of	O
desmocollin-2	PROT
Dsc2	O
,	O
one	O
of	O
the	O
ubiquitous	O
desmosomal	O
components	O
44	O
,	O
is	O
high	O
in	O
the	O
mutant	O
uterus	O
Figure	O
6K.The	O
membrane	O
was	O
probed	O
with	O
anti-ataxin-3	PROT
1H9	O
antibody	O
.	O
(	O
PPTX	O
186	O
kb	O
)	O
Glucocorticoid	O
receptor	O
localisation	O
in	O
mice	O
mammary	O
tumours	O
.	O
In	O
this	O
paper	O
,	O
we	O
have	O
presented	O
a	O
sparse	O
coding-based	O
model	O
,	O
to	O
simultaneously	O
representing	O
semantics	O
and	O
structure	O
of	O
threaded	O
discussions	O
.	O
To	O
localize	O
the	O
cis-acting	O
elements	O
responsible	O
for	O
this	O
instability	O
tendency	O
,	O
we	O
derived	O
lines	O
of	O
transgenic	O
mice	O
based	O
upon	O
the	O
original	O
13.5	O
kb	O
ataxin-7	PROT
genomic	O
fragment	O
,	O
deleting	O
a	O
large	O
region	O
∼8.3	O
kb	O
of	O
human	O
sequence	O
beyond	O
the	O
3′	O
end	O
of	O
the	O
CAG	O
tract	O
α-SCA7-92R	O
construct	O
.	O
Furthermore	O
,	O
Scammell	O
et	O
al	O
.	O
Differentiation	O
of	O
epithelial	O
progenitors	O
in	O
the	O
TEB	O
populates	O
the	O
ducts	O
with	O
mature	O
luminal	O
MECs	O
,	O
and	O
apoptosis	O
canalizes	O
the	O
lumen	O
.	O
It	O
has	O
been	O
shown	O
recently	O
that	O
the	O
human	O
SWI/SNF	O
subunit	O
Brm	O
,	O
involved	O
in	O
chromatin	O
remodelling	O
,	O
favours	O
the	O
inclusion	O
of	O
variant	O
exons	O
in	O
the	O
mRNA	O
of	O
several	O
genes	O
.	O
Spinocerebellar	O
ataxia	O
type	O
7	O
SCA7	O
is	O
an	O
autosomal	O
dominant	O
inherited	O
neurodegenerative	O
disorder	O
characterized	O
by	O
cerebellar	O
ataxia	O
and	O
visual	O
problems	O
due	O
to	O
a	O
progressive	O
loss	O
of	O
neurons	O
within	O
the	O
cerebellum	O
,	O
retina	O
and	O
brainstem	O
1	O
,2.The	O
data	O
represent	O
the	O
mean	O
±	O
SEM	O
for	O
three	O
individual	O
experiments	O
.	O
A	O
Normal	O
,	O
apoptotic	O
and	O
late	O
apoptoticnecrotic	O
cells	O
were	O
observed	O
by	O
staining	O
of	O
nuclear	O
DNA	O
with	O
Hoechst-33342	O
under	O
fluorescence	O
microscopy.As	O
a	O
deubiquitylase	O
,	O
ATX-3	O
is	O
highly	O
conserved	O
and	O
ubiquitously	O
expressed	O
in	O
cells	O
throughout	O
the	O
body	O
5	O
.	O
Negative	O
controls	O
for	O
immunohistochemistry	O
were	O
treated	O
without	O
primary	O
antibodies	O
,	O
and	O
positive	O
labelling	O
for	O
ataxin-3	PROT
aggregates	O
was	O
confirmed	O
in	O
pontine	O
neurons.TgHuC	O
:	O
EGFP	O
transgenic	O
embryos	O
uninjected	O
control	O
UIC	O
or	O
injected	O
with	O
ataxin-3	PROT
were	O
collected	O
for	O
TUNEL	O
staining	O
at	O
24	O
hpf	O
.	O
itga6	O
,	O
not	O
normally	O
expressed	O
in	O
muscle	O
at	O
4	O
dpf	O
,	O
is	O
observed	O
in	O
dystrophic	O
lesions	O
of	O
4	O
dpf	O
dag1	O
morphants	O
(	O
red	O
arrowheads	O
)	O
.	O
Comparison	O
of	O
CAG	O
repeat	O
length	O
change	O
revealed	O
that	O
ataxin-7	PROT
genomic	O
context	O
drives	O
repeat	O
instability	O
with	O
an	O
obvious	O
bias	O
toward	O
expansion	O
,	O
while	O
SCA7	O
CAG	O
repeats	O
introduced	O
on	O
ataxin-7	PROT
cDNAs	O
were	O
stable	O
13.These	O
changes	O
were	O
reflected	O
at	O
the	O
protein	O
level	O
as	O
determined	O
by	O
immunostaining	O
of	O
non-invasive	O
IT	O
lesions	O
and	O
broadly	O
invasive	O
IC2	O
lesions	O
.	O
(	O
Consequently	O
,	O
for	O
increased	O
flexibility	O
,	O
integrity	O
constraints	O
often	O
are	O
encoded	O
within	O
applications	O
,	O
usually	O
in	O
an	O
ad-hoc	O
manner	O
.	O
)	O
Introduction	O
This	O
year	O
,	O
the	O
Terabyte	O
Track	O
was	O
expanded	O
from	O
a	O
single	O
ad	O
hoc	O
task	O
to	O
include	O
an	O
efficiency	O
and	O
named-page	O
finding	O
task	O
.	O
All	O
adults	O
were	O
fed	O
fresh	O
chicken	O
liver	O
twice	O
weekly	O
.	O
We	O
concluded	O
,	O
on	O
the	O
basis	O
of	O
these	O
differentiation	O
assays	O
in	O
vitro	O
,	O
that	O
OCT4	O
transformed	O
a	O
stem	O
or	O
early	O
progenitor	O
cell	O
.	O
Colocalization	O
of	O
HuC	O
:	O
EGFP	O
green	O
and	O
TUNEL	O
positive	O
foci	O
red	O
in	O
the	O
telencephalon	O
region	O
B	O
and	O
diencephalonhindbrain	O
C.To	O
localize	O
the	O
cis-acting	O
elements	O
responsible	O
for	O
this	O
instability	O
tendency	O
,	O
we	O
derived	O
lines	O
of	O
transgenic	O
mice	O
based	O
upon	O
the	O
original	O
13.5	O
kb	O
ataxin-7	PROT
genomic	O
fragment	O
,	O
deleting	O
a	O
large	O
region	O
∼8.3	O
kb	O
of	O
human	O
sequence	O
beyond	O
the	O
3′	O
end	O
of	O
the	O
CAG	O
tract	O
α-SCA7-92R	O
construct	O
.	O
Mutation	O
of	O
Ip3r1	O
underlies	O
ataxia	O
in	O
mice	O
and	O
mutations	O
in	O
ITPR1	O
have	O
been	O
identified	O
in	O
spinocerebellar	O
ataxia	O
15	O
in	O
humans	O
17.GST-Ub	O
was	O
stained	O
by	O
Ponceau	O
S	O
,	O
and	O
the	O
pulled	O
down	O
proteins	O
were	O
analyzed	O
by	O
immunoblotting	O
with	O
anti-Flag	O
antibody	O
.	O
Finally	O
Section	O
2.3	O
identifies	O
different	O
maintenance	O
life-cycle	O
phases	O
.	O
Our	O
results	O
identify	O
CTCF	O
as	O
an	O
important	O
modifier	O
of	O
repeat	O
instability	O
in	O
SCA7	O
,	O
and	O
suggest	O
that	O
CTCF	O
binding	O
may	O
influence	O
repeat	O
instability	O
at	O
other	O
tandem	O
repeat	O
expansion	O
disease	O
loci.Although	O
the	O
ataxin-3	PROT
protein	O
is	O
known	O
to	O
be	O
ubiquitously	O
expressed	O
41	O
and	O
was	O
also	O
detected	O
in	O
stem	O
cells	O
in	O
the	O
intestine	O
Figure	O
4	O
,	O
we	O
can	O
not	O
exclude	O
the	O
possibility	O
that	O
the	O
lack	O
of	O
large	O
aggregates	O
in	O
the	O
stem	O
cells	O
is	O
possibly	O
also	O
due	O
to	O
a	O
lower	O
expression	O
of	O
the	O
protein	O
.	O
Similar	O
to	O
SRSF1	O
and	O
TDP-43	O
,	O
SRSF3	O
and	O
SRSF4	O
crosslinked	O
to	O
the	O
lincRNA	O
MALAT1	O
(	O
aka	O
NEAT2	O
;	O
Figure	O
S3a	O
in	O
Additional	O
file	O
1	O
)	O
that	O
is	O
enriched	O
in	O
nuclear	O
speckles	O
.	O
Thus	O
,	O
it	O
is	O
plausible	O
that	O
a	O
large	O
expansion	O
of	O
the	O
ATTCT	O
repeat	O
may	O
interfere	O
with	O
the	O
transcription	O
,	O
like	O
the	O
GAA	O
repeat	O
expansion	O
does	O
in	O
FRDA	O
,	O
leading	O
to	O
a	O
loss	O
of	O
function	O
of	O
ataxin	PROT
10.Aggresomes	O
remain	O
linked	O
to	O
only	O
one	O
centrosome	O
during	O
cell	O
division	O
,	O
which	O
raised	O
the	O
question	O
whether	O
asymmetric	O
inheritance	O
of	O
protein	O
aggregates	O
also	O
occurs	O
in	O
dividing	O
cells	O
of	O
polarised	O
tissues	O
and	O
what	O
the	O
implications	O
could	O
be	O
of	O
such	O
an	O
asymmetry	O
.	O
SCA3	O
is	O
caused	O
by	O
an	O
unstable	O
cytosine-adenine-guanine	O
CAG	O
trinucleotide	O
expansion	O
mutation	O
in	O
the	O
ATXN3	O
gene	O
leading	O
to	O
an	O
expanded	O
polyQ	O
tract	O
within	O
the	O
ataxin-3	PROT
ATX-3	O
protein	O
4.For	O
stable	O
over-expression	O
of	O
hnRNP	O
K	O
in	O
Sy5y	O
cells	O
,	O
pcDNA-hnRNP	O
K	O
was	O
digested	O
with	O
MfeI	O
and	O
the	O
linear	O
plasmid	O
DNA	O
was	O
tranefected	O
into	O
Sy5y	O
cells	O
using	O
Lipofectamin	O
2000	O
reagent	O
Invitrogen	O
,	O
and	O
the	O
stable	O
clones	O
were	O
selected	O
with	O
hygromycin	O
300	O
mgml	O
.	O
Sequences	O
were	O
retrieved	O
by	O
Basic	O
Local	O
Alignment	O
Search	O
Tool	O
(	O
BLAST	O
)	O
/BLAT	O
(	O
BLAST-like	O
Alignment	O
Tool	O
)	O
algorithm	O
using	O
chicken	O
Gal-1A	O
(	O
ENSGALG00000011480.3	O
)	O
peptide	O
sequence	O
as	O
input	O
.	O
In	O
S.	O
cerevisiae	O
,	O
different	O
stress	O
conditions	O
lead	O
to	O
formation	O
of	O
SGs	O
of	O
different	O
composition	O
,	O
and	O
with	O
different	O
assembly	O
requirements.Comparison	O
of	O
CAG	O
repeat	O
length	O
change	O
revealed	O
that	O
ataxin-7	PROT
genomic	O
context	O
drives	O
repeat	O
instability	O
with	O
an	O
obvious	O
bias	O
toward	O
expansion	O
,	O
while	O
SCA7	O
CAG	O
repeats	O
introduced	O
on	O
ataxin-7	PROT
cDNAs	O
were	O
stable	O
13	O
.	O
H	O
to	O
J	O
show	O
double	O
immuno-fluorescence-stained	O
neurons	O
.	O
Intestinal	O
tissue	O
contains	O
stem	O
cells	O
that	O
give	O
rise	O
to	O
short-lived	O
committed	O
progenitors	O
and	O
differentiated	O
cells.Cells	O
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
and	O
their	O
nuclear	O
DNA	O
was	O
stained	O
with	O
Hoechst-33342	O
for	O
detection	O
of	O
necrosis	O
and	O
apoptosis	O
by	O
morphological	O
features	O
.	O
In	O
fact	O
,	O
the	O
percentage	O
of	O
non–stem	O
cells	O
with	O
aggregates	O
in	O
the	O
crypts	O
of	O
both	O
patients	O
was	O
strikingly	O
high	O
,	O
whereas	O
stem	O
cells	O
containing	O
aggregates	O
were	O
never	O
detected	O
Figure	O
4K.We	O
identified	O
several	O
components	O
of	O
desmosomes	O
–	O
Dsp	O
,	O
Dsg2	O
,	O
desmocollin	PROT
2	O
Dsc2	O
;	O
MGI	O
:	O
103221	O
,	O
and	O
plakophilin	O
2	O
Pkp2	O
;	O
MGI	O
:	O
1914701	O
–	O
whose	O
expression	O
was	O
significantly	O
downregulated	O
in	O
the	O
highly	O
invasive	O
tumor	O
lesions	O
that	O
develop	O
in	O
the	O
RT2	O
mouse	O
model	O
of	O
PNET	O
.	O
Although	O
intestinal	O
dysfunction	O
is	O
not	O
obvious	O
in	O
patients	O
with	O
SCA3	O
,	O
this	O
tissue	O
provides	O
an	O
elegant	O
model	O
to	O
investigate	O
the	O
tissue	O
distribution	O
of	O
accumulated	O
mutant	O
ataxin-3	PROT
polyglutamine	O
protein	O
during	O
the	O
individual	O
's	O
lifespan.These	O
observations	O
suggest	O
that	O
disturbances	O
of	O
ITPR1-mediated	O
calcium	O
signaling	O
may	O
be	O
an	O
important	O
and	O
common	O
phenomenon	O
in	O
hereditary	O
ataxias	O
.	O
Interestingly	O
,	O
a	O
number	O
of	O
in	O
vivo	O
studies	O
have	O
demonstrated	O
that	O
TARDBP	O
has	O
a	O
number	O
of	O
genetic	O
interactors	O
such	O
as	O
Ataxin-2	PROT
46	O
,	O
progranulin	O
GRN	O
48	O
,	O
67–69	O
,	O
valosin-containing	O
protein	O
VCP	O
70	O
,	O
71	O
and	O
histone	O
deacetylase	O
6	O
HDAC6	O
36	O
,	O
38.Similar	O
data	O
were	O
obtained	O
with	O
the	O
anti–ataxin-3	PROT
antibody	O
unpublished	O
data	O
.	O
These	O
regions	O
are	O
enriched	O
for	O
genes	O
involved	O
in	O
synapse	O
formation	O
and	O
function	O
,	O
as	O
are	O
regions	O
with	O
patterns	O
of	O
reduced	O
variation	O
consistent	O
with	O
artificial	O
selection.Negative	O
controls	O
for	O
immunohistochemistry	O
were	O
treated	O
without	O
primary	O
antibodies	O
,	O
and	O
positive	O
labelling	O
for	O
ataxin-3	PROT
aggregates	O
was	O
confirmed	O
in	O
pontine	O
neurons	O
.	O
The	O
tumor	O
microenvironment	O
is	O
a	O
rich	O
milieu	O
of	O
cell	O
types	O
,	O
and	O
our	O
analyses	O
show	O
enrichment	O
of	O
many	O
cells	O
derived	O
from	O
mesenchyme	O
in	O
tumors	O
.	O
S7	O
and	O
,	O
Supplementary	O
Material	O
online	O
)	O
.	O
These	O
inclusions	O
were	O
not	O
detected	O
in	O
the	O
intestinal	O
crypts	O
of	O
healthy	O
controls	O
,	O
and	O
moreover	O
,	O
the	O
expression	O
levels	O
of	O
the	O
ataxin-3	PROT
protein	O
seemed	O
equal	O
in	O
all	O
cell	O
types	O
,	O
including	O
the	O
putative	O
stem	O
cells	O
see	O
below.In	O
these	O
putative	O
stem	O
cells	O
,	O
no	O
polyglutamine	O
inclusions	O
were	O
detected	O
Figure	O
4G	O
and	O
4H	O
.	O
